Composition and antimicrobial activity of Euphrasia rostkoviana Hayne essential oil

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Novy, Pavel ^a   Davidova, Hana ^a   Serrano Rojero, Cecilia Suqued ^a   Rondevaldova, Johana ^a   Pulkrabek, Josef ^a   Kokoska, Ladislav ^a  

^a CZECH UNIVERSITY OF LIFE SCIENCES PRAGUE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANETHOLE; CARVACROL; CIPROFLOXACIN; ESSENTIAL OIL; EUPHRASIA ROSTKOVIANA HAYNE ESSENTIAL OIL; HERBACEOUS AGENT; LAURIC ACID; LINALOOL; LINOLENIC ACID; MYRISTIC ACID; PALMITIC ACID; TERPINEOL; THYMOL; TIOCONAZOLE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CHEMICAL COMPOSITION; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; EUPHRASIA; EUPHRASIA ROSTKOVIANA HAYNE; KLEBSIELLA PNEUMONIAE; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM FUNGICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 84929376540     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/734101     Document Type: Article

References (26)

1. S. Darshan and R. Doreswamy, "Patented antiinfammatory plant drug development from traditional medicine", Phytotherapy Research, vol. 18, no. 5, pp. 343-357, 2004.
2. J. Barnes, L. A. Anderson, and J. D. Phillipson, Herbal Medicines, Pharmaceutical Press, London, UK, 3rd edition, 2007.
3. European Medicines Agency, Assessment Report on Euphrasia oficinalis L. and Euphrasia rostkoviana Hayne, Herba, A Report of Committee on Herbal Medicinal Products, European Medicines Agency, London, UK, 2010, http://www.ema.europa.eu/docs/en GB/document library/Herbal - HMPC assessment ment report/2011/01/WC500100385.pdf.
4. C. Lans, N. Turner, T. Khan, G. Brauer, and W. Boepple, "Ethnoveterinary medicines used for ruminants in British Columbia, Canada", Journal of Ethnobiology and Ethnomedicine, vol. 3, article 11, 2007.
5. M. Stoss, C. Michels, E. Peter, R. Beutke, and R. W. Gorter, "Prospective cohort trial of Euphrasia single-dose eye drops in conjunctivitis", Journal of Alternative and Complementary Medicine, vol. 6, no. 6, pp. 499-508, 2000.
6. L. Stofel, D. Zimmermann, R. Hunkeler et al., "Euphrasia eye drops in neonates: a pilot project", Schweizerische Zeitschrif fur GanzheitsMedizin, vol. 19, no. 5, pp. 254-259, 2007.
7. A. Trovato, M. T. Monforte, A. M. Forestieri, and F. Pizzimenti, "In vitro anti-mycotic activity of some medicinal plants containing favonoids", Bollettino Chimico Farmaceutico, vol. 139, no. 5, pp. 225-227, 2000.
8. R. Teixeira and L. R. Silva, "Bioactive compounds and in vitro biological activity of Euphrasia rostkoviana Hayne extracts", Industrial Crops and Products, vol. 50, pp. 680-689, 2013.
9. B. Blazics, Á. Alberti, S. Béni, L. Kursinszki, L. Tölgyesi, and Á. Kéry, "Identification and LC-MS-MS determination of acteoside, the main antioxidant compound of Euphrasia rostkoviana, using the isolated target analyte as external standard", Journal of Chromatographic Science, vol. 49, no. 3, pp. 203-208, 2011.
10. B. Blazics, K. Ludanyi, S. Szarka, and A. Kery, "Investigation of Euphrasia rostkoviana Hayne using GC-MS and LC-MS", Chromatographia, vol. 68, no. 1, pp. S119-S124, 2008.
11. K. J. Harkiss and P. Timmins, "Studies in the Scrophulariaceae part VIII1 phytochemical investigation of Euphrasia oficinalis", Planta Medica, vol. 23, no. 4, pp. 342-347, 1973.
12. D. L. Miladinovic, B. S. Ilic, D. M. Nikolic et al., "Volatile constituents of Euphrasia stricta", Chemistry of Natural Compounds, vol. 49, no. 6, pp. 1146-1147, 2014.
13. R. P. Adams, Identification of Essential Oil Components by Gas Chromatography/Mass Spectrometry, Allured Publishing Corporation, Carol Stream, Ill, USA, 4th edition, 2007.
14. Clinical and Laboratory Standards Institute, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically: Approved Standard, CLSI document M7-A8, Clinical and Laboratory Standards Institute, Wayne, Pa, USA, 8th edition, 2009.
15. A. V. Espinel-Ingrof and M. A. Pfaller, "Susceptibility test methods: yeasts and flamentous fungi", in Manual of Clinical Microbiology, P. R. Murray, E. J. Baron, J. H. Jorgensen, M. L. Landry, and M. A. Pfaller, Eds., ASM Press, Washington, DC, USA, 9th edition, 2007.
16. P. Cos, A. J. Vlietinck, D. V. Berghe, and L. Maes, "Anti-infective potential of natural products: how to develop a stronger in vitro 'proof-of-concept'", Journal of Ethnopharmacology, vol. 106, no. 3, pp. 290-302, 2006.
17. P. Novy, P. Kloucek, J. Rondevaldova, J. Havlik, L. Kourimska, and L. Kokoska, "Tymoquinone vapor significantly afects the results of Staphylococcus aureus sensitivity tests using the standard broth microdilution method", Fitoterapia, vol. 94, pp. 102-107, 2014.
18. S. De Rapper, G. Kamatou, A. Viljoen, and S. Van Vuuren, "The in vitro antimicrobial activity of Lavandula angustifolia essential oil in combination with other aroma-therapeutic oils", Evidence-based Complementary and Alternative Medicine, vol. 2013, Article ID 852049, 10 pages, 2013.
19. A. R. Bilia, F. Santomauro, C. Sacco, M. C. Bergonzi, and R. Donato, "Essential oil of Artemisia annua L.: an extraordinary component with numerous antimicrobial properties", Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 159819, 7 pages, 2014.
20. A. Stringaro, E. Vavala, M. Colone et al., "Efects of Mentha suaveolens essential oil alone or in combination with other drugs in Candida albicans", Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 125904, 9 pages, 2014.
21. Clinical and Laboratory Standards Institute, Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Third Informational Supplement, CLSI document M100-S19, Clinical and Laboratory Standards Institute, Wayne, Pa, USA, 2009.
22. M. A. El-Sherbeny, A. R. Maarouf, A. H. E. Hassan, and N. I. Abdel-Aziz, "Design and synthesis of new benzimidazole derivatives as potential antimicrobial agents", Journal of American Science, vol. 8, no. 12, pp. 785-798, 2012.
23. E. Lulekal, J. Rondevaldova, E. Bernaskova et al., "Antimicrobial activity of traditional medicinal plants from Ankober District, North Shewa Zone, Amhara Region, Ethiopia", Pharmaceutical Biology, vol. 52, no. 5, pp. 614-620, 2014.
24. M.-F. Moradali, H. Mostafavi, S. Ghods, and G. A. Hejaroude, "Investigation of antimicrobial fatty acids from medicinal artist conk mushroom Ganoderma applanatum (Pers.) Pat. (Aphyllophoromycetideae) by TLC and spectroscopic detection", International Journal of Medicinal Mushrooms, vol. 10, no. 2, pp. 149-154, 2008.
25. H. Zhang, L. Zhang, L.-J. Peng et al., "Quantitative structureactivity relationships of antimicrobial fatty acids and derivatives against Staphylococcus aureus", Journal of Zhejiang University: Science B, vol. 13, no. 2, pp. 83-93, 2012.
26. F. M. Dayrit, "The properties of Lauric acid and their significance in coconut oil", Journal of the American Oil Chemists' Society, vol. 92, no. 1, pp. 1-15, 2015.